Office of the Assistant Secretary for Planning and Evaluation; Advisory Council on Alzheimer's Research, Care, and Services, 16505 [2013-06065]

Share |
Download as PDF Federal Register / Vol. 78, No. 51 / Friday, March 15, 2013 / Notices Dickson, Fairfax, Minnesota; each to acquire voting shares of Fort Ridgely National Bancorporation, Inc., and thereby indirectly acquire voting shares of First National Bank of Fairfax, both in Fairfax, Minnesota. Board of Governors of the Federal Reserve System, March 12, 2013. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2013–06006 Filed 3–14–13; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Assistant Secretary for Planning and Evaluation; Advisory Council on Alzheimer’s Research, Care, and Services Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. ACTION: Request for Nominations. srobinson on DSK4SPTVN1PROD with NOTICES AGENCY: SUMMARY: HHS is soliciting nominations for a new, non-Federal member of the Advisory Council on Alzheimer’s Research, Care, and Services to fill the position of representative of a voluntary health association as described in Public Law 111–375 (42 U.S.C. 11225). Nominations should include the nominee’s contact information (current mailing address, email address, and telephone number) and current curriculum vitae or resume. DATES: Submit nominations by email or FedEx or UPS before COB on April 12, 2013. ADDRESSES: Nominations should be sent to Helen Lamont at helen.lamont@hhs.gov; Helen Lamont, Ph.D., Office of the Assistant Secretary for Planning and Evaluation, Room 424E Humphrey Building, Department of Health and Human Services, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Helen Lamont (202) 690–7996, helen.lamont@hhs.gov. SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer’s Research, Care, and Services meets quarterly to discuss programs that impact people with Alzheimer’s disease and related dementias and their caregivers. The Advisory Council makes recommendations about ways to reduce the financial impact of Alzheimer’s disease and related dementias and to improve the health outcomes of people with these conditions. The Advisory Council provides feedback on the National Plan to Address Alzheimer’s VerDate Mar<14>2013 17:37 Mar 14, 2013 Jkt 229001 Disease. On an annual basis, the Advisory Council shall evaluate the implementation of the recommendations through an updated national plan. The Advisory Council consists of designees from Federal agencies including the Centers for Disease Control and Prevention, Administration on Aging, Centers for Medicare and Medicaid Services, Indian Health Service, Office of the Director of the National Institutes of Health, National Science Foundation, Department of Veterans Affairs, Food and Drug Administration, Agency for Healthcare Research and Quality, and the Surgeon General. The Advisory Council also consists of 12 non-federal members selected by the Secretary who are Alzheimer’s patient advocates (2), Alzheimer’s caregivers (2), health care providers (2), representatives of State health departments (2), researchers with Alzheimer’s-related expertise in basic, translational, clinical, or drug development science (2), and voluntary health association representatives (2). Members serve for overlapping 4 year terms, except that any member appointed to fill a vacancy for an unexpired term shall be appointed for the remainder of such term. A member may serve after the expiration of the member’s term until a successor has taken office. Members serve as Special Government Employees. This announcement is seeking nominations for a ‘‘representative of a voluntary health association’’ who is not a Federal employee. Donald B. Moulds, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2013–06065 Filed 3–14–13; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of Exclusive License: Chimeric West Nile/Dengue Viruses Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 16505 Services (HHS), is thinking about giving an exclusive license, in the field of use of in vitro diagnostics for dengue virus infection, to practice the inventions listed in the patent applications referred to below to CTK Biotech Inc., having a place of business in San Diego, California. The patent rights in these inventions have been assigned to the government of the United States of America. The patent applications(s) to be licensed are: U.S. Provisional Application 61/049,342, filed 4/30/2008, entitled ‘‘Engineered, Chimeric West Nile/Dengue Viruses;’’ PCT Application PCT/US2009/041824, filed 4/27/2009, entitled ‘‘Engineered, Chimeric WN/Flavivirus as Reagents to Enhance Flavivirus Diagnostics and Vaccine Development;’’ U.S. National Stage Application 12/990,322, filed 10/29/2010, entitled ‘‘Chimeric West Nile/Dengue Viruses;’’ and all related continuing and foreign patents/patent applications for the technology family. CDC Technology ID No. I– 020–08. Status: Pending. Priority Date(s): 4/30/2008. The planned exclusive license will bring in royalties and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Technology HHS/CDC has developed chimeric West Nile/Dengue viruses which express the immunogenic premembrane (prM) and envelope (E) surface proteins of dengue virus (DEN) in the genetic background of a West Nile (WN) virus. The genetic background in the chimeric virus contains the nonstructural genes of the WN virus. Due to the robust replication ability of WN virus, whose nonstructural proteins control replication in the chimeric virus, the WN/DEN virus exhibits much more robust viral replication in cell cultures, compared to the slow growing DEN viruses. The chimeric WN/DEN virus can be used as a substitute for wild-type dengue virus in multiple applications, including diagnostics, vaccine development, vaccine testing, and biological research. These applications are highly important to public health by offering improvements in DEN diagnostics and prevention of DEN viral disease. DATES: Only written comments and/or applications for a license which are received by HHS/CDC on or before April 15, 2013 will be considered. ADDRESSES: Requests for a copy of these patent applications, inquiries, comments, and other materials relating to the planned license should be directed to Donald Prather, J.D., Ph.D., Technology Licensing and Marketing E:\FR\FM\15MRN1.SGM 15MRN1

Agencies

[Federal Register Volume 78, Number 51 (Friday, March 15, 2013)]
[Notices]
[Page 16505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06065]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Office of the Assistant Secretary for Planning and Evaluation; 
Advisory Council on Alzheimer's Research, Care, and Services

AGENCY: Department of Health and Human Services, Office of the 
Assistant Secretary for Planning and Evaluation.

ACTION: Request for Nominations.

-----------------------------------------------------------------------

SUMMARY: HHS is soliciting nominations for a new, non-Federal member of 
the Advisory Council on Alzheimer's Research, Care, and Services to 
fill the position of representative of a voluntary health association 
as described in Public Law 111-375 (42 U.S.C. 11225). Nominations 
should include the nominee's contact information (current mailing 
address, email address, and telephone number) and current curriculum 
vitae or resume.

DATES: Submit nominations by email or FedEx or UPS before COB on April 
12, 2013.

ADDRESSES: Nominations should be sent to Helen Lamont at 
helen.lamont@hhs.gov; Helen Lamont, Ph.D., Office of the Assistant 
Secretary for Planning and Evaluation, Room 424E Humphrey Building, 
Department of Health and Human Services, 200 Independence Avenue SW., 
Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Helen Lamont (202) 690-7996, 
helen.lamont@hhs.gov.

SUPPLEMENTARY INFORMATION: The Advisory Council on Alzheimer's 
Research, Care, and Services meets quarterly to discuss programs that 
impact people with Alzheimer's disease and related dementias and their 
caregivers. The Advisory Council makes recommendations about ways to 
reduce the financial impact of Alzheimer's disease and related 
dementias and to improve the health outcomes of people with these 
conditions. The Advisory Council provides feedback on the National Plan 
to Address Alzheimer's Disease. On an annual basis, the Advisory 
Council shall evaluate the implementation of the recommendations 
through an updated national plan.
    The Advisory Council consists of designees from Federal agencies 
including the Centers for Disease Control and Prevention, 
Administration on Aging, Centers for Medicare and Medicaid Services, 
Indian Health Service, Office of the Director of the National 
Institutes of Health, National Science Foundation, Department of 
Veterans Affairs, Food and Drug Administration, Agency for Healthcare 
Research and Quality, and the Surgeon General. The Advisory Council 
also consists of 12 non-federal members selected by the Secretary who 
are Alzheimer's patient advocates (2), Alzheimer's caregivers (2), 
health care providers (2), representatives of State health departments 
(2), researchers with Alzheimer's-related expertise in basic, 
translational, clinical, or drug development science (2), and voluntary 
health association representatives (2). Members serve for overlapping 4 
year terms, except that any member appointed to fill a vacancy for an 
unexpired term shall be appointed for the remainder of such term. A 
member may serve after the expiration of the member's term until a 
successor has taken office. Members serve as Special Government 
Employees. This announcement is seeking nominations for a 
``representative of a voluntary health association'' who is not a 
Federal employee.

Donald B. Moulds,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2013-06065 Filed 3-14-13; 8:45 am]
BILLING CODE P